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Introduction 
Behçet’s disease is an inflammatory disorder that usually in-
volves multiple-organ.1) According to the International Study 
Group for Behçet’s disease, the diagnostic criteria of Behçet’s 
disease are recurrent oral ulceration plus 2 of the followings: 
recurrent genital ulceration, skin lesions, uveitis, and positive 
pathergy test.2) Various systemic manifestations can be oc-
curred including arthritis, gastrointestinal symptoms, and neu-
rologic complications.3) Behçet’s disease that involve the heart 
or aorta, such as aortitis and aortic valve regurgitation (AR), is 
usually less than 2%4) based on case reports but is frequently 
associated with significant mortality and morbidity. Also, Be-
hçet’s disease can affect conduction system, and atrioventricular 
(AV) conduction impairment is one of the rare manifestation 
of cardiac involvement.5)6) Surgical intervention in this inflam-
matory condition carries a high risk of postoperative morbidi-
ty because of the fragilities of aortic structures and tissue in-
flammation.7) We report a patient of Behçet’s disease, whose 
first manifestations were rapidly aggravated AV conduction 
impairment, and then acutely developed severe AR that suc-
cessfully treated with bridging immunosuppressant and ho-
mograft of ascending aorta and aortic root and aortic valve re-
placement surgery.
Case
A 50-year-old man visited emergency room for acute onset 
of New York Heart Association class IV dyspnea for 1 day. He 
had past medical history of essential hypertension for 10 years 
and of minimal coronary artery disease on coronary angiogra-
phy (CAG) undertaken 6 months ago for evaluation of non-
specific chest pain. On that time, electrocardiogram (ECG) 
showed his rhythm was 1st degree AV block (Fig. 1A) and the 
transthoracic echocardiography (TTE) showed mild left ven-
tricular (LV) hypertrophy (LV mass = 98 g/m2) without any 
valvular dysfunctions. Because there was no significant find-
ings in 24 hours holter monitoring, he was discharged with-
out any treatment. After 5 months later, he revisited out-pa-
tient clinic for syncope twice during playing golf. The ECG 
showed complete AV block (Fig. 1B) and after electrophysio-
logic study of AV node, DDD type permanent pacemaker was 
implanted. On the TTE examination of 2nd admission, mild 
LV hypertrophy was still noted without interval change but 
mild degree of AR was noted (Fig. 2A and B).
On this time, his blood pressure was 110/70 mm Hg and 
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pulse rate was 88 beats per minute. On physical examination, 
there were grade IV/VI diastolic murmur at the left middle 
sternal border and rale at both lung fields. Chest X-ray showed 
pulmonary congestion on both lower lung fields. ECG showed 
right ventricle pacing beats of P wave tracing by permanent 
pacemaker (Fig. 1C). On the TTE examination, newly devel-
oped severe AR (Fig. 2C and D) was noted and transesopha-
geal echocardiography revealed non-coronary cusp of aortic 
valve billowing and prolapsing (Fig. 2E) with aortic root dila-
tation (4.0 cm). In the laboratory examinations, cardiac en-
zymes were normal, white blood count was 15,900/mm3, 
erythrocyte sedimentation rate was 31 mm/hr and C-reactive 
protein was 3.94 mg/dL. We performed blood culture, al-
though there was no fever, and found out that the blood cul-
ture was negative. And the patients had no concurrent symp-
toms suggestive of infective endocarditis. Considering rapidly 
progressing (during 5 months) conduction disorder and wors-
ening of valvular regurgitation (during 1 month), we suspect-
ed of cardiac involvement of systemic inflammatory disease. 
On history taking, the patient had recurrent oral ulcer without 
arthritis, genital ulcer or uveitis. Pathergy test was negative. 
Even though the patient’s clinical finding did not fulfill the 
diagnostic criteria of Behçet’s disease, patient’s clinical history 
and echocardiography findings was enough to suspect of car-
diac involvement of Behçet’s disease. The patient was treated 
with steroid (prednisolone 80 mg once daily) and immunosup-
pressants (azathioprine 175 mg once daily) for 3 months and 
showed good clinical responses without symptom aggravations. 
After bridging immunosuppressive therapy, open heart sur-
gery for homograft of ascending aorta and aortic root and aor-
tic valve replacement with bioprosthesis (bovine pericardium, 
#25 mm) was performed. On the pathologic examination of 
surgical specimen, there were no evidence of infection such as 
endothelialitis or abscess formation. The gross finding of re-
sected aortic valve and aorta showed light white colored ten-
der leaflet and aorta wall without calcification. The micro-
scopic finding showed fibromyxoid valvulopathy and myxoid 
change of aorta wall. The follow-up transthoracic echocardio-
gam on 1 year after open heart surgery with maintenance of 
azathioprine showed no AR or aortic dilatation with normal 
LV function and dimension (Fig. 2F and G). 
Discussion
Behçet’s disease affects multi-organ and there were well 
known diagnostic criteria of this disease.1)2) Cardiac manifesta-
tions of Behçet’s disease are myocarditis, AV block, pericarditis, 
coronary and valvular involvement, particularly of the aortic 
valve, and intracardiac thrombosis (right atrial and ventricular 
thrombosis).8)9) Behçet’s disease was found to be the cause of 
AR in 7 of 153 consecutive patients requiring aortic surgery 
in a Korean series10) which suggestive of underdiagnosis of Be-
hçet’s disease as an etiology of AR in current clinical practice. 
One of the reason for this underdiagnosis is that preoperative 
diagnosis of Behçet’s disease mainly depends on history and 
the identification of its typical clinical manifestations due to 
absence of characteristic pathognomic findings.11) In one study, 
of the 15 patients with AR and Behçet’s disease, only 4 pa-
tients were completely fulfilled the current criteria of Behçet’s 
disease. These show that the usefulness of current diagnostic 
criteria is limited in terms of identifying Behçet’s disease as 
the underlying etiology of AR.12) Severe and symptomatic AR 
is usually required surgical intervention. However, because of 
tissue fragility, surgical treatment for AR in Behçet’s disease is 
commonly associated with recurrent regurgitation due to para-
valvular leakage, valvular detachment, hemorrhage, and pseu-
doaneurysm formation.4)13) Also, the management of inflamma-
tory vasculitis required immunosuppressive therapy to prevent 
postoperative complications.4) Therefore, an early and correct 
diagnosis of aortic valve involvement by Behçet’s disease is re-
quired to decide an appropriate treatment strategy. And there 
Fig. 1. A: ECG finding of 1st admission on 6 months ago when patient complaint of chest pain shows 1st degree AV block. B: ECG finding of 1 month 
ago when patient complaint of 2 times of syncope shows complete AV block. C: ECG finding when patients was complaint severe dyspnea on 
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has been a concern that current diagnostic criteria may delay 
the diagnosis of Behçet’s disease.12) In our case, the patient’s 
clinical history of recurrent oral ulcer was the only finding that 
match with the current diagnostic criteria of Behçet’s disease, 
and the diagnosis of Behçet’s disease was not made till devel-
opment of manifest aortic valvulitis with severe AR. Although 
our patient failed to meet the diagnostic criteria, we suspected 
Behçet’s aortic valvulitis with patient’s clinical and echocar-
diographic findings. And then, we started immunosuppres-
sive therapy.
Behçet’s disease firstly manifested by conduction system 
impairment is seldom founded.5)6) In our case, there was no 
other possible etiology of complete AV block other than Be-
hçet’s disease. Coronary arterial disease and coronary angiitis 
were excluded by normal CAG. Therefore, we conclude that 
the complete AV block was related with Behçet’s disease in-
volving conduction system. Although the etiology of the con-
duction impairment in Behçet’s disease is not exactly known, 
Fig. 2. A and B: TTE findings of 1 month ago when patient complaint of 2 times of syncope in parasternal long axis (A) and apical 5 chamber view (B) 
show aortic valve regurgitation of mild degree. C and D: On the TTE findings when patients was complaint severe dyspnea on emergency room 
shows severe aortic valve regurgitation in parasternal long axis (C) and apical 5 chamber view (D). E: On TEE examination, aortic valve thickening and 
billowing with redundant cusp (white arrows) is noted. F and G: The follow-up TTE on 1 year after open heart surgery showed no AR or aortic 
dilatation with normal LV function and dimension in parasternal long axis (F) and apical 5 chamber view (G). TTE: transthoracic echocardiography, 
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inflammation of AV node and surrounding conduction system 
has been suggested as causes of the impairment of conduc-
tion.14) In conclusion, this case report is about rare clinical 
manifestation of Behçet’s disease with rapidly progressive AV 
conduction delay first, and then rapidly deteriorating aortic 
valve function to severe regurgitation. We observed this rapid 
progression within 6 months and under the impression of Be-
hçet’s disease, we performed bridging immunosuppressive 
therapy with open heart surgery and maintenance immuno-
suppressive therapy for 1 year as treatment. As a result, the 
patient is doing well without any aggravation of cardiac mani-
festations so far.
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